Skip to main content
Beta Drugs Limited logo

Beta Drugs Limited — Investor Relations & Filings

Ticker · BETA ISIN · INE351Y01019 LEI · 984500A89888DB9E6T57 National Stock Exchange of India Manufacturing
Open in API
Filings indexed 431 across all filing types
Latest filing 2019-07-03 Regulatory Filings
Country IN India
Listing National Stock Exchange of India BETA

About Beta Drugs Limited

https://www.betadrugslimited.com

Beta Drugs Limited specializes in the development, manufacture, and marketing of oncology formulations. The company provides a comprehensive portfolio of anti-cancer drugs across various therapeutic segments, including cytotoxic injectables, lyophilized products, tablets, and capsules. Its manufacturing capabilities encompass a wide range of oncology treatments such as chemotherapy agents and supportive care medications. The organization operates advanced production facilities designed to meet international quality standards, focusing on high-potency active pharmaceutical ingredients and finished dosage forms. The company serves diverse markets through its own branded products and contract manufacturing services, aiming to provide affordable and high-quality cancer care solutions. Its core competency lies in its specialized focus on the oncology niche and its integrated approach to pharmaceutical production.

Recent filings

Filing Released Lang Actions
Changes in Shareholding
Regulatory Filings Classification · 90% confidence The document text contains only placeholders for images and no textual content or substantive information. The true document length is only 110 characters, indicating it is extremely short and lacks any report or announcement details. There is no indication of any report, announcement, or filing type. Given the absence of content, the document cannot be classified as a specific report or announcement. Therefore, it falls under the fallback category of Regulatory Filings (RNS).
2019-07-03 English
Updates
Major Shareholding Notification Classification · 95% confidence The document contains multiple disclosures related to share allotments under preferential issues and changes in shareholding by promoters and directors. It references the Securities and Exchange Board of India (SEBI) Prohibition of Insider Trading Regulations, 2015, specifically Regulation 6(2) and 7(2), which require disclosures of share transactions by insiders. The document includes detailed tables of share allotments, dates, and numbers of shares allotted to promoters and directors. There is no indication of a full financial report, earnings release, or management discussion. Instead, the document is a regulatory disclosure of insider share transactions and allotments under SEBI regulations. This fits the category of Major Shareholding Notification (MRQ), which covers notifications of changes in significant share ownership levels, including preferential allotments to promoters and insiders.
2019-07-03 English
Trading Window
Regulatory Filings Classification · 95% confidence The document is a letter addressed to the National Stock Exchange of India Limited regarding the non-applicability of the trading window closure for the April to June 2019 quarter. It references a circular from NSE and SEBI regulations about trading restrictions related to financial results announcements. The document is short (1484 characters) and serves as a regulatory communication or clarification rather than a financial report or announcement of results. It does not contain financial data, management discussion, or detailed report content. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements and compliance communications that do not fit other specific categories.
2019-07-02 English
Outcome of Board Meeting
Share Issue/Capital Change Classification · 95% confidence The document contains a table listing names and addresses of allottees along with the number of shares allotted to each. This indicates it is related to share allotment or issuance. There is no indication of a full financial report, audit, or management discussion. The document length is very short (533 characters), and it is not a report but an announcement or record of share allotment. Therefore, it fits best under the category of Share Issue/Capital Change (SHA).
2019-07-01 English
Shareholders meeting
AGM Information Classification · 95% confidence The document is a detailed record of a shareholders' meeting, including resolutions passed regarding related party transactions, preferential issue of shares, and approvals under the Companies Act, 2013. It includes voting results and procedural details typical of minutes or proceedings of a general meeting. The content focuses on shareholder approvals and corporate governance actions rather than financial statements or earnings data. The presence of resolutions, voting by poll, and detailed procedural text indicates this is a record of an Annual General Meeting or an Extraordinary General Meeting. Given the detailed nature of the meeting proceedings and resolutions, this fits best under AGM Information (AGM-R).
2019-06-29 English
Shareholders meeting
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a detailed disclosure of the outcome of an Extraordinary General Meeting (EGM) held on 28th June 2019 by Beta Drugs Limited. It includes resolutions passed regarding related party transactions, share acquisition, and preferential issue of shares. It also contains voting results of the EGM. The content is focused on the meeting proceedings, resolutions passed, and voting outcomes rather than a full financial report or earnings release. The presence of voting results and detailed resolutions indicates this is a Declaration of Voting Results & Voting Rights Announcements (DVA). The document is lengthy and contains substantive details of the meeting and voting, not just a brief announcement or a report publication notice. Therefore, the correct classification is DVA.
2019-06-28 English

Browse filings by year

10 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.